查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386578

間質幹細胞市場報告：2030 年趨勢、預測與競爭分析

Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

間質幹細胞的發展趨勢與預測

2030年，全球間間質幹細胞市場預計將達到66億美元，2024年至2030年的年複合成長率為13.1%。這個市場的主要驅動力是糖尿病、癌症和自體自體免疫疾病等慢性疾病的盛行率不斷上升，再生醫學的吸引力不斷增強，以及利用間質幹細胞創造創新治療方法的目標。生物製藥公司的研發工作正在迅速推進增加。全球間質幹細胞市場的未來在疾病建模、藥物研發發現和開發、幹細胞庫、組織工程和毒性研究市場方面前景廣闊。

間質幹細胞市場洞察

Lucintel注意到間質幹細胞在臨床使用中的強大安全實績，間質幹細胞的移植是一項突破，因為它們不太可能引發免疫反應並且具有免疫抑制特性。我們預測它將成為一種細胞為本治療方法。

間質幹細胞在預測期內將繼續成長，因為目前美國正在進行臨床試驗，旨在評估其作為多種危及生命的疾病的潛在治療選擇的有效性和安全性。北美仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球間間質幹細胞市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球間間質幹細胞市場趨勢（2018-2023）與預測（2024-2030）
  • 按工作流程分類的全球間間質幹細胞市場
    • 細胞採購與分離
    • 培養及冷凍保存
    • 差異化
    • 特性評價
  • 按類型分類的全球間間質幹細胞市場
    • 自體的
    • 同種異體的
  • 全球間間質幹細胞市場（依應用）
    • 疾病建模
    • 藥物研發發現和發現
    • 幹細胞庫
    • 人體組織工程
    • 毒理學研究
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球間間質幹細胞市場
  • 北美間間質幹細胞市場
  • 歐洲間質幹細胞市場
  • 亞太間間質幹細胞市場
  • 其他區域間質幹細胞市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按工作流程分類的全球間間質幹細胞市場成長機會
    • 全球間間質幹細胞市場成長機會（按類型）
    • 全球間間質幹細胞市場成長機會（依應用）
    • 全球間間質幹細胞市場成長機會（按地區）
  • 全球間間質幹細胞市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球間間質幹細胞市場的產能
    • 全球間間質幹細胞市場的合併、收購及合資企業
    • 認證和許可

第7章 主要企業概況

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • BrainStorm Cell
  • Stemedica Cell Technologies
  • Merck
簡介目錄

Mesenchymal Stem Cell Trends and Forecast

The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets. The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

A more than 150-page report is developed to help in your business decisions.

Mesenchymal Stem Cell by Segment

The study includes a forecast for the global mesenchymal stem cell by workflow, type, application, and region.

Mesenchymal Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

Mesenchymal Stem Cell Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Autologous
  • Allogeneic

Mesenchymal Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Mesenchymal Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mesenchymal stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mesenchymal stem cell companies profiled in this report include-

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • Brainstorm Cell
  • Stemedica Cell Technologies
  • Merck

Mesenchymal Stem Cell Market Insights

Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Features of the Global Mesenchymal Stem Cell Market

Market Size Estimates: Mesenchymal stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Mesenchymal stem cell market size by workflow, type, application, and region in terms of value ($B).

Regional Analysis: Mesenchymal stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, type, application, and regions for the mesenchymal stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mesenchymal stem cell market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mesenchymal stem cell market size?

Answer: The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030.

Q.2 What is the growth forecast for mesenchymal stem cell market?

Answer: The global mesenchymal stem cell market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mesenchymal stem cell market?

Answer: The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

Q4. What are the major segments for mesenchymal stem cell market?

Answer: The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets.

Q5. Who are the key mesenchymal stem cell market companies?

Answer: Some of the key mesenchymal stem cell companies are as follows:

  • Thermo Fisher Scientific
  • Cell Applications
  • Axol Biosciences
  • Cytori Therapeutics
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen
  • Brainstorm Cell
  • Stemedica Cell Technologies
  • Merck

Q6. Which mesenchymal stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

Q7. In mesenchymal stem cell market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the mesenchymal stem cell market by workflow (cell sourcing & isolation, culture & cryopreservation, differentiation, and characterization), type (autologous and allogeneic), application (disease modelling, drug development & discovery, stem cell banking, tissue engineering, toxicology studies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Mesenchymal Stem Cell Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Mesenchymal Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Mesenchymal Stem Cell Market by Workflow
    • 3.3.1: Cell Sourcing & Isolation
    • 3.3.2: Culture & Cryopreservation
    • 3.3.3: Differentiation
    • 3.3.4: Characterization
  • 3.4: Global Mesenchymal Stem Cell Market by Type
    • 3.4.1: Autologous
    • 3.4.2: Allogeneic
  • 3.5: Global Mesenchymal Stem Cell Market by Application
    • 3.5.1: Disease Modelling
    • 3.5.2: Drug Development & Discovery
    • 3.5.3: Stem Cell Banking
    • 3.5.4: Tissue Engineering
    • 3.5.5: Toxicology Studies
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Mesenchymal Stem Cell Market by Region
  • 4.2: North American Mesenchymal Stem Cell Market
    • 4.2.1: North American Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.2.2: North American Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.3: European Mesenchymal Stem Cell Market
    • 4.3.1: European Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.3.2: European Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.4: APAC Mesenchymal Stem Cell Market
    • 4.4.1: APAC Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.4.2: APAC Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others
  • 4.5: ROW Mesenchymal Stem Cell Market
    • 4.5.1: ROW Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
    • 4.5.2: ROW Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Workflow
    • 6.1.2: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Type
    • 6.1.3: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Application
    • 6.1.4: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Region
  • 6.2: Emerging Trends in the Global Mesenchymal Stem Cell Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Mesenchymal Stem Cell Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Mesenchymal Stem Cell Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Cell Applications
  • 7.3: Axol Biosciences
  • 7.4: Cytori Therapeutics
  • 7.5: STEMCELL Technologies
  • 7.6: Cyagen Biosciences
  • 7.7: Celprogen
  • 7.8: BrainStorm Cell
  • 7.9: Stemedica Cell Technologies
  • 7.10: Merck